119 related articles for article (PubMed ID: 2566682)
1. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
Galitzky J; Lafontan M; Paris H; Berlan M
J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
[TBL] [Abstract][Full Text] [Related]
2. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
5. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
6. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
Schloos J; Wellstein A; Palm D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
[TBL] [Abstract][Full Text] [Related]
7. Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
Galitzky J; Mauriege P; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 May; 249(2):583-91. PubMed ID: 2566681
[TBL] [Abstract][Full Text] [Related]
8. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
Thomsen WJ; Jacquez JA; Neubig RR
Mol Pharmacol; 1988 Dec; 34(6):814-22. PubMed ID: 2904647
[TBL] [Abstract][Full Text] [Related]
10. New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
Galitzky J; Larrouy D; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1990 Jan; 252(1):312-9. PubMed ID: 1967647
[TBL] [Abstract][Full Text] [Related]
11. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
12. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
Convents A; De Backer JP; Convents D; Vauquelin G
Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
[TBL] [Abstract][Full Text] [Related]
13. Density of alpha-2A adrenoceptors and Gi proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age.
Sastre M; García-Sevilla JA
J Pharmacol Exp Ther; 1994 Jun; 269(3):1062-72. PubMed ID: 7912275
[TBL] [Abstract][Full Text] [Related]
14. Imidazolinic radioligands for the identification of hamster adipocyte alpha 2-adrenoceptors.
Saulnier-Blache JS; Carpéné C; Langin D; Lafontan M
Eur J Pharmacol; 1989 Nov; 171(2-3):145-57. PubMed ID: 2575998
[TBL] [Abstract][Full Text] [Related]
15. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
[TBL] [Abstract][Full Text] [Related]
16. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
Taouis M; Berlan M; Lafontan M
Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
[TBL] [Abstract][Full Text] [Related]
18. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-adrenoceptor in HT29 human colon adenocarcinoma cell-line: study of [3H](-)-adrenaline binding.
Sénard JM; Mauriège P; Daviaud D; Paris H
Eur J Pharmacol; 1989 Mar; 162(2):225-36. PubMed ID: 2566497
[TBL] [Abstract][Full Text] [Related]
20. Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung.
Gleason MM; Hieble JP
J Pharmacol Exp Ther; 1991 Dec; 259(3):1124-32. PubMed ID: 1684814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
